Results 131 to 140 of about 29,503 (186)
Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy. [PDF]
Nat CommunZheng T, Ramanathan K, Ormhøj M, Hansen MR, Halldórsdóttir HR, Li H, Munk KK, Rodriguez-Pardo C, Friis RUW, Seder I, Heegaard PMH, Qvortrup K, Abken H, Sun Y, Hadrup SR. +14 moreeuropepmc +1 more sourceDetection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM. [PDF]
Cancer DiscovPearlman AH, Wang Y, Kalluri A, Parker M, Cohen JD, Dudley J, Rincon-Torroella J, Xia Y, Gensler R, Alfonzo Horowitz M, Theodore JN, Dobbyn L, Popoli M, Ptak J, Silliman N, Judge K, Calabresi PA, Groves M, Jackson CM, Jackson EM, Jallo GI, Lim M, Luciano M, Mukherjee D, Naidoo J, Rozati S, Sterling CH, Weingart J, Koschmann C, Mansouri A, Glantz M, Kamson D, Schreck KC, Pardo CA, Holdhoff M, Konig MF, Paul S, Kinzler KW, Papadopoulos N, Vogelstein B, Douville C, Bettegowda C. +41 moreeuropepmc +1 more sourceSurvival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer. [PDF]
ESMO OpenMorganti S, Kusmick RJ, Hughes ME, Brasó-Maristany F, Smith K, Tarantino P, Vega-Leon R, Grinda T, Pardo F, Dvir K, Suggs GL, Buck S, Skeffington M, Garrido-Castro AC, Parsons HA, Sammons SL, Prat A, Lin NU, Tolaney SM, Giordano A. +19 moreeuropepmc +1 more sourceStage at Diagnosis and International Survival Variation in Childhood Tumors in the BENCHISTA Study. [PDF]
JAMA Netw OpenBotta L, Didonè F, Lopez-Cortes A, Cañete Nieto A, Desandes E, Hjalgrim LL, Jakab Z, Stiller CA, Zeller B, Bailey S, Gaspar N, Spreafico F, Strauss SJ, Gatta G, Pritchard-Jones K, BENCHISTA Project Working Group. +15 moreeuropepmc +1 more sourceQuantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer. [PDF]
NPJ Precis OncolTarantino P, Kim SE, Hughes ME, Kusmick RJ, Smith K, Brasó-Maristany F, Nyein Chan NN, Paré Brunet L, Alder L, Garcia-Cortes D, Gomez Tejeda Zanudo J, Pereslete AM, Noteware L, Moore H, Van Swearingen AED, Li T, Gupta H, D'Amico O, Martini A, Morganti S, Spindel J, Cook C, McLaughlin C, Dvir K, Garrido-Castro AC, Sammons S, Files J, Sendrick K, Buck S, Dillon D, Jeselsohn R, Li YY, Cherniack AD, LoRusso P, Lustberg M, Vega-León R, Pardo F, Davis J, Mueller C, Corgiat B, Curigliano G, Anders CK, Petricoin EF, Rimm DL, Prat A, Tayob N, Lin NU, Tolaney SM. +47 moreeuropepmc +1 more sourceImmunologic effects of locoregional therapies for unresectable hepatocellular carcinoma. [PDF]
JHEP RepSchmidt R, Gebauer B, Akbari N, Roderburg C, Torsello GF, Fehrenbach U, Auer TA, Mohr R, Ardila Pardo GL, Lim W, Pivetta F, Can E, Hamm CA, Tacke F, Hamm B, Hammerich L, Savic LJ. +16 moreeuropepmc +1 more sourceIn vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kν10.1
, 2016 Alves, F., Hartung, F., Napp, J., Pardo, L., Stühmer, W., Tietze, L. +5 morecore +1 more source